Please assess the completion status of the following clinical trial:

Trial Title: Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed adenocarcinoma of the prostate~  * Locally advanced disease or at high risk for relapse~* No clinically or radiologically suspected metastases~* Prior lymphadenectomy required~* Meets at least 1 of the following criteria for poor prognosis:~  * Gleason score greater than 7~ * T3 or T4 disease~ * Prostate-specific antigen greater than 20 ng/mL~ * N1 disease~PATIENT CHARACTERISTICS:~Age~* Under 80~Performance status~* ECOG 0-2~Life expectancy~* More than 10 years~Hematopoietic~* Absolute neutrophil count greater than 1,500/mm\^3~* Platelet count at least 100,000/mm\^3~Hepatic~* AST and ALT no greater than 1.5 times upper limit of normal (ULN)~* Bilirubin no greater than ULN~Renal~* Creatinine less than 1.6 mg/dL OR~* Creatinine clearance greater than 60 mL/min~Cardiovascular~* No uncontrolled or severe cardiovascular disease~* No prior thrombosis~Pulmonary~* No prior pulmonary embolus~Other~* No active infection~* No intolerance to aspirin~* No other prior malignancy except basal cell skin cancer~* No physical or psychological condition that would preclude study compliance~PRIOR CONCURRENT THERAPY:~Biologic therapy~* No concurrent immunotherapy~Chemotherapy~* No prior chemotherapy~* No other concurrent chemotherapy~Endocrine therapy~* No prior hormonal therapy~* No other concurrent hormonal therapy~Radiotherapy~* Not specified~Surgery~* See Disease Characteristics~Other~* No other concurrent anticancer therapy

- Gender: MALE
- Minimum Age: 0 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Chemotherapy (Type: EXPERIMENTAL): None
- Without Chemotherapy (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).